SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Faustino, P. Articles by Lavinha, J. Search for Related Content PubMed PubMed Citation Articles by Faustino, P. Articles by Lavinha, J. Related Collections Red Cells Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, Vol. 91 No. 2 (January 15), 1998: pp. 685-690 Dominantly Transmitted -Thalassemia Arising From the Production of Several Aberrant mRNA Species and One Abnormal Peptide By Paula Faustino, Leonor Osório-Almeida, Luísa Romão, José Barbot, Berta Fernandes, Benvindo Justiça, and João Lavinha From the Departamento de Genética Humana, Instituto Nacional de Saúde Dr Ricardo Jorge, Lisboa; the Laboratório de Genética Molecular, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Monte da Caparica; and the Serviço de Hematologia, Hospital de Santo António, Porto, Portugal.     ABSTRACT Abstract Introduction Methods Results Discussion References We describe a dominantly inherited -thalassemia intermedia phenotype observed in a five-generation Portuguese family. Carriers are characterized by moderate anemia, hypochromia, microcytosis, elevated hemoglobin (Hb)A2 and HbF levels, splenomegaly, hepatomegaly, and inclusion bodies in pheripheral red blood cells after splenectomy. The molecular basis of this condition is a small deletion within the 5 consensus splicing sequence of the second intron of the -globin gene, IVS-II-4,5 (-AG). Reticulocyte RNA studies performed by reverse transcription-polymerase chain reaction (RT-PCR) and primer extension analysis showed three abnormally processed transcripts, which, upon sequencing, were shown to correspond to (1) skipping of exon 2, and (2) activation of two cryptic splice sites (between codons 59/60, and at IVS-II-47). In vitro translation studies of these patients' reticulocyte RNA have shown that at least one of these aberrant mRNA species is translated into an abnormally elongated peptide whose cytotoxic properties could, in part, be causing the atypical dominant mode of inheritance observed in this family. We suggest that this elongated  chain is unable to combine with an -globin chain to form a functional Hb molecule. Its degradation would, then, exhaust the proteolytic defense mechanism of the erythroid precursors, leading to inefficient proteolysis of the free  chains in excess.     INTRODUCTION Abstract Introduction Methods Results Discussion References THE -THALASSEMIAS ARE usually transmitted as autosomal-recessive disorders.1 However, some dominant forms of -thalassemia have been identified in individuals who have inherited a single copy of an abnormal -globin gene and a normal -globin genotype. Thalassemia intermedia with mild anemia, jaundice, and splenomegaly was observed in these patients, as well as elevated hemoglobin (Hb)A2 and HbF levels, unbalanced -/-chain synthesis ratio, and presence of inclusion bodies in the erythroid precursors and peripheral red blood cells after splenectomy.2,3 The molecular basis of these dominant -thalassemias is heterogeneous, with the majority of them being associated with mutations in the third exon, and a few located in the first and second exons of the -globin gene4: frameshift and nonsense mutations or complex rearrangements lead to the synthesis of highly unstable truncated or elongated -globin products.3 The main factors that determine the phenotype appear to be the length of the globin gene product, its ability to bind heme or to form functional / dimers and 2/2 tetramers, and the stability of the latter in the developing erythroid precursors and in peripheral red blood cells. The continuous degradation of these nonfunctional  chains adds an extra burden to the proteolytic defense mechanism of the erythrocytic precursors, such that proteolysis of the free  chains is compromised. This leads to accumulation and precipitation of  chains to a greater extent than observed in the classical asymptomatic -thalassemia heterozygotes. In some cases, the precipitation of the abnormal  chain is observed.3,5 Most of the mammalian genes are interrupted by introns, which are removed from mRNA precursors by the splicing machinery. At the 5 and 3 ends of each intron, dinucleotides GT and AG, respectively, are invariably present.6,7 Flanking these invariant dinucleotides are sequences that are fairly well conserved. Mutations within these sequences in the -globin gene have been described that reduce, to various degrees, the efficiency of normal splicing, giving rise to abnormal globin mRNAs and producing a +-thalassemia phenotype.8-10 Here, we describe the functional effects of a dominantly transmitted -thalassemia determinant, detected in a large Portuguese family presenting -thalassemia intermedia.11 The molecular basis of this condition is a deletion of nucleotides 4 and 5 of the -globin gene IVS-II consensus donor splicing sequence, which leads, in vivo, to three abnormally spliced -globin mRNAs and, in vitro, to an abnormal -globin peptide. This -globin gene mutation provides another good model for investigating the relationship between -globin gene structure and function.     MATERIALS AND METHODS Abstract Introduction Methods Results Discussion References Subjects.   In this study, we analyzed 24 members of a five-generation Portuguese family in which -thalassemia intermedia is inherited as a Mendelian autosomal-dominant condition (Fig 1). The disease, characterized by moderate anemia with jaundice, splenomegaly, and hepatomegaly, is transmitted vertically through different generations. The propositus (IV21) received occasional blood transfusions until 11 years of age, when he underwent a splenectomy. Before this, his spleen and liver were enlarged (9 cm and 7.5 cm below the respective costal margins). Other members of the family (IV3 and IV7) also underwent splenectomy. View larger version (14K): [in this window] [in a new window]   Fig 1. Pedigree of Portuguese family shows segregation of dominantly transmitted -thalassemia determinant. Propositus is marked by arrow. () Athal; () anti3.7/; () normal tested; () dead; () sex unknown, individual not studied. All remaining individuals were not studied. Hematologic analysis.   Red blood cell indices were obtained with an automated cell counter. Hb analysis was performed by cellulose acetate electrophoresis at pH 8.4, isoelectrofocusing (IEF), and reverse-phase high-performance liquid chromatography (HPLC). HbA2 was quantitated by DEAE cellulose chromatography and HbF was determined by an alkali denaturation method.12 Serum iron and serum ferritin were assayed by standard methods. Globin chain synthesis was determined as previously described.13 Inclusion bodies were detected in perypheral erythrocytes after incubation with brilliant cresyl blue.14 To detect unstable Hb, the isopropanol precipitation test was performed as previously described.15 DNA analysis.   Total genomic DNA was isolated from peripheral leukocytes by a salting-out procedure,16 followed by micro phenol/chloroform extraction. -globin haplotyping17 was performed by Southern blotting18,19 or by digestion of the appropriate polymerase chain reaction (PCR) product.20 The -globin gene cluster was mapped by Southern blotting by using BamHI and BglII and genomic probes specific for - and -globin genes, or by enzymatic amplification analysis using two primer sets that allow the specific amplification of the 1- and 2-globin genes.21 Allele-specific oligonucleotides22 or restriction endonuclease analysis of amplified DNA were used to investigate the most frequent -thalassemia mutations found in the Mediterranean populations.11 Both oligonucleotide and genomic probes were radioactively labeled with phosphorus 32.22,23 The sequencing of the -globin genes from the propositus was performed on amplified double-stranded DNA by the dideoxy method24 using the Sequenase Kit Version 2.0 (US Biochemical, Cleveland, OH). RNA analysis.   Total RNA was isolated from peripheral reticulocytes by phenol extraction of acid-precipitated polysomes as previously described.25 One microgram of total RNA was reverse-transcribed into cDNA by the random hexamer priming method using AMV reverse transcriptase (RT; Pharmacia Biotech, Uppsala, Sweden) at 42°C for 1 hour. The -globin cDNA was then enzymatically amplified using the following primer set located within exon 1 and exon 3 of the -globin gene: 5-AAGTCTGCCGTTACTGCCCT-3 (forward) and 5-CACTTTCTGATAGGCAGCCTGC-3 (reverse). The amplification products were then electrophoresed on a denaturant urea/formamide/polyacrylamide vertical gel and visualized directly upon ethidium bromide staining. Each fragment was extracted from the gel, reamplified with a nested pair of primers, purified, and sequenced by the dideoxy method.24 Quantitative analysis of the -globin mRNAs was performed by primer extension. The reverse primer 5-GTGATACTTGTGGGCCAGAT-3, located at exon 3 of the -globin gene, was 5 end-labeled with [32P]adenosine triphosphate (ATP),22 hybridized to 1 µg of total reticulocyte RNA, and extended with RT as previously described.26 The products obtained were separated by 6% polyacrylamide gel electrophoresis under denaturing conditions. Band intensities on autoradiographs were quantitated by densitometry (Sharp Scanner JX-330; Image Master Software Phoretix, Pharmacia Biotech, Uppsala, Sweden). Protein analysis.   One microgram of total RNA was translated in vitro27 at 30°C for 1 hour, using a micrococcal nuclease-treated rabbit reticulocyte lysate (Promega, Madison, WI) in the presence of L-[35S]methionine (Amersham, Buckinghamshire, England). The labeled translation products were separated on a TritonX-100/acid/urea 12% polyacrylamide gel28 and autoradiographed. The -/-globin biosynthetic ratio was determined by excising from the dried gel the newly synthesized - and -globin chains and quantification by liquid scintillation counting (Beckman Instruments, Fullerton, CA). As a blank control, a piece of gel of the same size was used. To determine the molecular weight of the in vitro translation products, these were excised from the Triton X-100/acid/urea-dried gel and separated on a 18% sodium dodecyl sulfate (SDS)-polyacrylamide gel.29     RESULTS Abstract Introduction Methods Results Discussion References Hematologic analysis.   The patients investigated in this study showed a hypochromic, microcytic moderate anemia. The blood smear showed anisocytosis, poikilocytosis, target cells, some erythroblasts, and basophilic stippling in the erythrocytes. Separation of Hb fractions either by cellulose acetate electrophoresis or isoelectrofocusing failed to detect any abnormal Hbs. The levels of HbA2 and HbF were increased in the affected members. A marked decrease in -globin chain synthesis was observed. Brilliant cresyl blue staining showed a large percentage of inclusion bodies in the peripheral erythrocytes of the splenectomized patients. The available hematologic and globin genotypic data in the studied family members are listed in Table 1.   View this table: [in this window] [in a new window]   Table 1. Available Hematologic and Globin Genotypes in Family Members Studied DNA analysis.   Seven of the common thal mutations present in Mediterranean populations were not found in the propositus. However, the sequencing of the -globin genes showed a two-nucleotide deletion (-AG) within the IVS-II 5 splice site consensus sequence [IVS-II-4,5 (-AG)]11 (Fig 2). As this deletion eliminates a normal HinfI restriction site, its presence was easily confirmed in other affected family members by restriction digestion of the appropriate -globin gene PCR fragment. This genetic alteration was not found in any of the nonaffected family members, or in a number of normal controls. Haplotype analysis in the -globin gene cluster demonstrated that this -thalassemia mutation was linked to haplotype Va.17 We also observed, in a branch of this family, the segregation of triplicated -globin gene haplotype anti3.7. Three patients (III14, IV21, and IV22) were double heterozygotes for triplicated -globin gene and the thal mutation. View larger version (86K): [in this window] [in a new window]   Fig 2. Direct sequencing of exon2/intron2 -globin gene region of amplified double-strand DNA from propositus, using a forward primer, which shows the 2-nucleotide deletion (-AG) at position IVS-II-4,5. Deletion was confirmed by sequencing the same DNA region using an appropriate reverse primer. RNA analysis.   In an attempt to characterize the functional effect of the IVS-II-4,5 (-AG) mutation on the processing of the -globin gene primary transcript, we analyzed the peripheral reticulocyte -globin mRNA in the propositus and in normal controls. By RT-PCR, we detected four -globin mRNA species of different sizes (Fig 3A), which, upon sequencing, turned out to be (1) a normal -globin mRNA; (2) an aberrant mRNA, 224 nt shorter than normal due to exon 2 skipping; (3) an aberrant mRNA, 135 nt shorter than normal, resulting from the activation of a cryptic splice site in exon 2 between codons 59/60 (AG/gtgaag); and (4) an aberrant mRNA, 45 nt longer than normal, resulting from the activation of a cryptic splice site at IVS-II-47 (TG/gttaag). These are schematically represented in Fig 3B. Quantitative analysis of the abnormal -globin mRNAs species was performed by primer extension followed by densitometric scanning of the gel autoradiograph (Fig 3D). This failed to show any significant difference in the relative abundance of the three abnormal mRNA species. View larger version (84K): [in this window] [in a new window]   View larger version (16K): [in this window] [in a new window]   View larger version (51K): [in this window] [in a new window]   View larger version (47K): [in this window] [in a new window]   Fig 3. Effect of dominantly inherited -thalassemia mutation on -globin expression. (A) Denaturant urea/formamide/polyacrylamide vertical gel electrophoresis of fragments obtained by RT-PCR from reticulocyte -globin mRNAs extracted from (1) a carrier (IV7) of IVS-II-4,5(-AG) mutation (4 -globin mRNAs species of different size were found, which, on sequencing, were shown to correspond to the normal -globin mRNA [N], exon 2 skipping [E2S], and activation of 2 cryptic splice sites between codon 59/60 [CS 59/60] and at IVS-II-47 [CS IVS-II-47]); (2) a normal -globin control; and (3) DNA molecular weight marker (pBR322 + BglI + HinfI). (B) Schematic representation of the 3 abnormally processed -globin transcripts. Arrows under exons represent primers used in RT-PCR. x, stop codon position. (C) Amino acid sequence of normal human -globin chain and predicted amino acid sequence corresponding to various aberrant -globin transcripts. Differences in amino acid sequence are underlined. Deleted residues are indicated by dashed line. (D) Primer extension analysis of -globin mRNA (using a reverse primer located at -globin gene exon 3, 5 end-labeled with [32P]dATP) in (1) a normal control; (2) a carrier of IVS-II-4,5 (-AG) mutation (showing the normal and 3 abnormal mRNA species, which, upon densitometric scanning, showed no significant difference in its relative abundance; and (3) 5 end-labeled DNA molecular weight marker (pGEM 3 + HinfI). Protein analysis.   With the aim to detect the translation products of the abnormal -globin mRNAs, we in vitro-translated patient (IV7, IV14, and V6) and normal control total reticulocyte RNA. The products obtained were separated according to their electrical charge on a TritonX100/acid/urea polyacrylamide gel. In the patients, we detected an abnormal slower-moving band in addition to the normal globins (Fig 4). In vitro translation time-course experiments were performed in which aliquots were removed at regular intervals (0, 10, 20, 30, and 60 minutes) and applied to the same type of gel. No abnormal unstable peptide was observed. To characterize the abnormal peptide above by its molecular weight, we excised the pieces of dried gel that corresponded to the abnormal peptide and normal globin chains and loaded them on a 18% SDS-polyacrylamide gel. Under these experimental conditions, the abnormal slower-moving band showed a molecular weight higher than normal globins, suggesting it was the translation product of the longer abnormal -globin mRNA (CS IVS-II-47). In vitro translation of reticulocyte RNA from a patient (IV14) showed a -/-globin chain synthesis ratio similar to the one observed in -thalassemia heterozygotes: / = 0.53. This ratio clearly indicates a reduction of the -globin chain biosynthetic capacity. View larger version (75K): [in this window] [in a new window]   Fig 4. In vitro translation of total reticulocyte RNA isolated from peripheral blood samples of (1) a normal -globin control, (2 and 3) a carrier (IV7, V6) of IVS-II-4,5 (-AG) mutation, (4) a newborn normal -globin control, and (5) an in vitro translation reaction to which no exogenous RNA was added. The 35S-labeled translation products were resolved in a Triton-acid-urea polyacrylamide gel. The position of , °, , G, , and A globins are indicated on the left of the autoradiograph. Abnormal peptide is marked by an arrow.     DISCUSSION Abstract Introduction Methods Results Discussion References The study of naturally occurring mutations within the human -globin gene cluster has greatly contributed to understand the mechanisms of gene expression. Most of the naturally occurring mutations and the in vitro-generated mutations that reduce the complementarity of the 5 donor splice site with U1 SnRNP result in authentic 5 splice-site function inactivation or reduction and several aberrant splicing events occur.30 Here, we describe a dominantly inherited -thalassemia mutation associated with a thalassemia intermedia phenotype, located near the 5 splice junction of intron 2 of the -globin gene, IVS-II-4,5 (-AG), and characterize its effect on gene expression, namely, on RNA splicing. The analysis of reticulocyte RNA isolated from these patients showed three abnormally processed -globin transcripts. The abnormal mRNA species originated by exon 2 skipping is 224 nt shorter than normal. The skipping of exon 2 results in a shift of the reading frame, which leads to a partial readthrough of the 3 untranslated sequence of  globin mRNA until a new in-phase termination codon is encountered 11 codons downstream. If this aberrant mRNA were translated, the corresponding peptide would have an extremely altered amino acid sequence from residue 29 through to its C-terminal end (Fig 3C). Certainly, it would not be a functional globin chain. The other aberrant mRNA species, 135 nt shorter than normal, results from the activation of a cryptic splice site between codons 59/60 in exon 2 keeping the reading in frame. So, the possible peptide originated by its translation would have 45 fewer amino acid residues (59-104) than normal, corresponding to the 3 portion of the second exon (Fig 3C). This truncated -globin gene product is expected not to bind heme, as drastic alterations in its structure occur and therefore leave it nonfunctional. Finally, the aberrant transcript that results from the activation of a cryptic splice site in the IVS-II-47 is 45 nt longer than normal and keeps the reading frame. The -globin chain corresponding to this abnormal mRNA species would have an insertion of 15 amino acid residues between R104 and L105 (Fig 3C), within helix-G (G5) of the -globin chain. Four 11 contact points thought to be essential for dimer formation and, subsequently, for the Hb tetramer assembly are located within G-helix at positions 108, 112, 115, and 116.31,32 The introduction of 15 amino acid residues within G-helix would probably interfere with those contact points, preventing the abnormal  chain from combining with chains to form a Hb tetramer, thus leading to ineffective erythropoiesis. However, it is possible that heme binding is responsible for the maintenance of some native secondary structure and probably this chain is less susceptible to proteolytic degradation than those without heme. The continuous degradation of these abnormal, nonfunctional  variants would add an extra burden to the proteolytic defence mechanism of the erythroid precursors, such that proteolysis of free  chains is compromised. It is therefore probable that the unstable, elongated  chain, in addition to the concomitant excess of  chains, precipitates in the differentiating red blood cell to form inclusion bodies. These, in fact, are observed in patients' blood smears after splenectomy. Our studies performed by in vitro translation (including a time-course incubation) have shown that one of the abnormal mRNA species was translated into protein (Fig 4). We observed that the abnormal peptide has a molecular weight higher than the normal globin chains, suggesting it is the translation product of the abnormal mRNA resulting from the activation of a cryptic splice site at IVS-II-47. The accurate and efficient selection of both 5 and 3 splice sites is clearly a complex process. Consensus values (CV), as a measure of complementarity to U1 snRNP, were calculated for the normal and mutated 5 splice site sequences of the -globin IVS-II and for the two activated cryptic splice site sequences using the method described by Shapiro and Senapathy.7 The mutation originates a drastic decrease in the score of the 5 splice site sequence from 0.889 (GG/gtgagt) to 0.634 (GG/gtgtct). The selection of these cryptic splice sites can be understood on the basis of its higher score: 0.782 (AG/gtgaag), 135 nt upstream, and 0.739 (TG/gttaag) 45 nt downstream. Following this reasoning, selection of one 3 splice site, out of the two possible sites lying in intron I or II, should be determined by the strength of their splice signals. The score of the 3 splice site of the second intron is much higher than that of the first intron.33 In this way, the 3 splice site of the second intron is powerfully selected, giving rise to exon 2 skipping, as observed in this case. Several point mutations within the intron 5 splicing consensus region and their effects on gene expression have been reported in a number of human disorders.34 The only other thal mutation located in the IVS-II 5 splice site sequence that has been characterized at functional level, IVS-II-1 (G  A), results in two abnormal -globin mRNAs: the predominant RNA species, with an insertion of the first 47 nucleotides of the IVS-II between exons 2 and 3, and a minor species resulting from the normal first exon being directly spliced to the third.35 This suggests, in comparison to the expression effect of our mutation, that different nucleotide positions within the donor consensus splice-site sequence may play different roles in splice-site selection and in the kinetics of splicing. It is also noteworthy that, in our case, although the same cryptic splice site, at IVS-II-47, has been activated, the two-nucleotide deletion results in a different reading frame, with completely different results at the protein, cell, and organism levels.     FOOTNOTES    Submitted January 21, 1997; accepted September 8, 1997.    P.F. was supported by a research fellowship from Junta Nacional de Investigação Científica e Tecnológica (JNICT) and PRAXIS XXI. Supported in part by JNICT research grants.    Address reprint requests to João Lavinha, PhD, Departamento de Genética Humana, Instituto Nacional de Saúde Dr Ricardo Jorge, Avenida Padre Cruz, P-1699 Lisboa CODEX, Portugal.    The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.     ACKNOWLEDGMENT We thank A. Villegas for performing the globin chain biosynthetic assay, and M.J. Peres, I. Picanço, A. Miranda, and T. Seixas for technical assistance. We also thank L. Pinho for providing further patient blood samples for analysis.     REFERENCES Abstract Introduction Methods Results Discussion References 1. Weatherall DJ, Clegg JB: The Thalassemia Syndromes (ed 3). New York, NY, Blackwell Scientific Publications, 1981 2. Thein SL, Hesketh C, Taylor P, Temperley IJ, Hutchinson RM, Old JM, Wood WG, Clegg JB, Weatherall DJ: Molecular basis for dominantly inherited inclusion body -thalassemia. Proc Natl Acad Sci USA 87:3924, 1990[Abstract/Free Full Text] 3. Thein SL: -Thalassemia, in Higgs DR, Weatherall DJ (eds): The Haemoglobinopathies, vol 2. London, UK, Saunders, 1993, p 151 4. Baysal K, Carver MFH: The - and -Thalassemia Repository (eighth edition). Hemoglobin 92:176, 1995 5. Weatherall DJ, Clegg JB, Knox-Macaulay HHM: A genetically determined disorder with features both of thalassemia and congenital dyserythropoietic anaemia. Br J Haematol 24:681, 1973[Medline] [Order article via Infotrieve] 6. Mount SM: A catalogue of splice junction sequences. Nucleic Acids Res 10:459, 1982[Abstract/Free Full Text] 7. Shapiro MB, Senapathy P: RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155, 1987[Abstract/Free Full Text] 8. Treisman T, Orkin SH, Maniatis T: Specific transcription and RNA splicing defects in five cloned -thalassemia genes. Nature 302:591, 1983[Medline] [Order article via Infotrieve] 9. Lapoumeroulie C, Acuto S, Rouabhi F, Labie D, Krishnamoorthy R, Bank A: Expression of a  thalassemia gene with abnormal splicing. Nucleic Acids Res 15:8195, 1987[Abstract/Free Full Text] 10. Atweh GF, Wong C, Reed R, Antonarakis SE, Zhu D, Ghosh PK, Maniatis T, Forget BG, Kazazian HH: A new mutation in IVS-1 of the human  globin gene causing  thalassemia due to abnormal splicing. Blood 70:147, 1987[Abstract/Free Full Text] 11. Faustino P, Osório-Almeida L, Barbot J, Espírito-Santo D, Gonçalves J, Romão L, Martins MC, Marques MM, Lavinha J: Novel promoter and splice junction defects add to the genetic, clinical or geographic heterogeneity of -thalassemia in the Portuguese population. Hum Genet 89:573, 1992[Medline] [Order article via Infotrieve] 12. Betke K, Marti HR, Schlicht I: Estimation of small percentages of foetal haemoglobin. Nature 184:1877, 1959 13. Clegg JB: The thalassaemias, in Weatherall DJ (ed): Methods in Haematology. Oxford, UK, Churchill Livingstone, 1983, p 74 14. Papayannopoulou T, Stamatoyannopoulos G: Stains for inclusions bodies, in Schmidt RM, Huisman THJ, Lehmann H (eds): The Detection of Hemoglobinopathies. Cleveland, OH, CRC Press, 1974, p 32 15. Huisman THJ, Jonxis JHP: The Hemoglobinopathies Techniques of Identification, vol 6. New York, NY, Marcel Dekker, 1977 16. Miller SA, Dykes DD, Polesky HF: A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988[Free Full Text] 17. Orkin SH, Kazazian HH, Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJV: Linkage of -thalassemia mutations and -globin gene polymorphisms with DNA polymorphisms in the human -globin gene cluster. Nature 296:627, 1982[Medline] [Order article via Infotrieve] 18. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503, 1975[Medline] [Order article via Infotrieve] 19. Reed KC, Mann DA: Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res 13:7207, 1985[Abstract/Free Full Text] 20. Semenza GL, Dowling CE, Kazazian HH Jr: HinfI polymorphism 3 to the human -globin gene detected by polymerase chain reaction (PCR). Nucleic Acids Res 17:2376, 1989[Free Full Text] 21. Dodé C, Krishnamoorthy R, Lamb L, Rochette J: Rapid analysis of 3.7 thalassaemia and anti3.7 triplication by enzymatic amplification analysis. Br J Haematol 82:105, 1992 22. Pirastu M, Kan YW, Cao A, Conner BJ, Teplitz RL, Wallace RB: Prenatal diagnosis of  thalassaemia. Detection of a single nucleotide mutation in DNA. N Engl J Med 309:284, 1983[Abstract] 23. Feinberg AP, Vogelstein B: A new technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983[Medline] [Order article via Infotrieve] 24. Dodé C, Rochett J, Krishnamoorthy R: Locus assignment of human  globin mutations by selective amplification and direct sequencing. Br J Haematol 76:275, 1990[Medline] [Order article via Infotrieve] 25. Liebhaber SA, Kan YW: -Thalassemia caused by an unstable -globin mutant. J Clin Invest 71:461, 1983 26. Townes TM, Lingrel JB, Chen HY, Brinster RL, Palmiter RD: Erythroid-specific expression of human -globin genes in transgenic mice. EMBO J 4:1715, 1985[Medline] [Order article via Infotrieve] 27. Liebhaber SA, Cash FE, Shankin SH: Translationally associated helix-destabilizing activity in rabbit reticulocyte lysate. J Biol Chem 259:15597, 1984[Abstract/Free Full Text] 28. Rovera G, Magarian C, Borun TW: Resolution of haemoglobin subunits by electrophoresis in acid urea polyacrylamide gels containing Triton X-100. Anal Biochem 85:506, 1978[Medline] [Order article via Infotrieve] 29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970[Medline] [Order article via Infotrieve] 30. Nelson KK, Green MR: Mechanism for cryptic splice site activation during pre-mRNA splicing. Proc Natl Acad Sci USA 87:6253, 1990[Abstract/Free Full Text] 31. Murru S, Poddie D, Sciarratta GV, Agosti S, Baffico M, Melevendi C, Pirastu M, Cao A: A novel -globin structural mutant, Hb Brescia (114 Leu-Pro), causing a severe -thalassaemia intermedia phenotype. Hum Mut 1:124, 1992[Medline] [Order article via Infotrieve] 32. Dickerson RE, Geis I: Hemoglobin: Structure, Function, Evolution, and Pathology. Menlo Park, CA, Benjamin/Cummings, 1983 33. Iida Y: Quantification analysis of splice signal sequences. Exon skipping in -globin gene of thalassemia. Nucleic Acids Symp Ser 29:161, 1993 34. Krawczak M, Reiss J, Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum Genet 90:41, 1992[Medline] [Order article via Infotrieve] 35. Treisman R, Nicholas J, Proudfoot, Shander M, Maniatis T: A single-base change at a splice site in a ° thalassaemic gene causes abnormal RNA splicing. Cell 29:90, 1982 © 1998 by The American Society of Hematology.   0006-4971/98/91-0010$3.00/0 CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: M. Margaglione, R. Santacroce, D. Colaizzo, D. Seripa, G. Vecchione, M. R. Lupone, D. De Lucia, P. Fortina, E. Grandone, C. Perricone, et al. A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing Blood, October 1, 2000; 96(7): 2501 - 2505. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal